The present Policy Brief was developed by the Asian Network of People who Use Drugs (ANPUD) to stimulate and support the meaningful participation of its constituents – Asian people who use drugs – in the UNGASS 2016 process. Following a short overview of the UNGASS process, the Brief highlights common issues across the region that have been prioritized by ANPUD with specific recommendations.
In 2014, ANPUD has agreed to partner with HIV/ AIDS Asia Regional Program (HAARP) in supporting the meaningful involvement of people who use drugs (PWUD) in all areas of harm reduction policy and program implementation. This includes developing skills of people who use drugs in Lao PDR, Cambodia and Vietnam through the development and implementation of capacity building activities (including training modules) in consultation with country stakeholders.
Research conducted by ANPUD in India, Indonesia, Malaysia and Nepal found that none of the health service providers who participated in the survey provided hepatitis C treatment, and most didn’t know where testing and treatment was available or how much it cost.
ANPUD calls on all states in the Asia region to end their use of compulsory drug detention centres and to support the implementation of a variety of quality drug treatment options for PUD. There is an urgent need for the scaling up of human rights-based, evidence-informed and voluntary drug treatment including opioid substitution treatment, detoxification and rehabilitation services.
This advocacy strategy is informed by study investigation on the issues and barriers faced by PWID in relation to hepatitis C infection in India, Indonesia, Malaysia, and Nepal; and by an advocacy strategy planning and development worskhop held in Bangkok on 28th-30th November, 2011.
This document provide a detail recording of the first ANPUD meeting on the 16th and 17th October 2009 taking place in Somerset Lake Point, Bangkok, Thailand
Harm reduction refers to policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive drugs in people unable or unwilling to stop.